Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Vaxart Stock Is Under Pressure Today

TheMotleyFool

0 0

Why Vaxart Stock Is Under Pressure TodayPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png

Vaxart (NASDAQ: VXRT), a clinical-stage vaccine developer, is poised for a tough day today. Ahead of the opening bell, the biotech's shares dropped by as much as 9.9%.

The culprit? Vaxart's stock is sinking this morning in response to an 8-K filed with the Securities and Exchange Commission (SEC) last Wednesday. In the filing, Vaxart revealed that it is currently under investigation by the federal government and the SEC for its prior claims about being selected by Operation Warp Speed (OWS). What's more, the company also released details regarding the ongoing class action lawsuits filed by some of its shareholders over the same matter.

Image source: Getty Images.

Source Fool.com

Like: 0

VXRT

Teilen